Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Monocytic, Acute × Observation × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Neoplasms 4 Lung Neoplasms 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Oropharyngeal Neoplasms 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Trauma, Nervous System 1 Thoracic Injuries 1 Surgical Wound Dehiscence 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Retinoblastoma 1 Rectal Neoplasms 1 Radiculopathy 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 Pilonidal Sinus 1 Pathologic Complete Response 1

Interventions

Injections 2 Gemtuzumab 2 Decitabine 2 ruxolitinib 1 fludarabine 1 fedratinib 1 Whole-Body Irradiation 1 Thiotepa 1 Tacrolimus 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Methotrexate 1 Daunorubicin 1 Cytarabine 1 Cyclosporins 1 Cyclosporine 1 Cyclophosphamide 1 Busulfan 1 Biopsy 1 Azacitidine 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡